These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23865791)

  • 1. YKL-40 and EGFR is a good biomarker for predicting nodal metastasis in anal carcinoma.
    Yang Y; Yang JJ; Tao H; Jin WS
    Colorectal Dis; 2014 Jan; 16(1):69. PubMed ID: 23865791
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact.
    Mistrangelo M; Senetta R; Racca P; Castellano I; Chiusa L; Bellò M; Ricardi U; Morino M; Cassoni P
    Colorectal Dis; 2013 Nov; 15(11):1382-91. PubMed ID: 23692332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival.
    Castellano I; Mistrangelo M; Crudo V; Chiusa L; Lupo R; Ricardi U; Morino M; Mussa A; Cassoni P
    Histopathology; 2009 Aug; 55(2):238-40. PubMed ID: 19694834
    [No Abstract]   [Full Text] [Related]  

  • 4. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
    Horbinski C; Wang G; Wiley CA
    Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
    Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
    Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metadata checklist: identification of CHI3L1 and MASP2 as a biomarker pair for liver cancer through integrative secretome and transcriptome analysis.
    Ding W; Qiu Q; Liu G; Liu J; Mao R; Lin B
    OMICS; 2014 Oct; 18(10):658-61. PubMed ID: 25133456
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers.
    Stawerski P; Wągrowska-Danilewicz M; Stasikowska-Kanicka O; Danilewicz M
    Pathol Res Pract; 2011 Sep; 207(9):573-6. PubMed ID: 21820815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YKL-40 expression could be a poor prognostic marker in the breast cancer tissue.
    Kang EJ; Jung H; Woo OH; Park KH; Woo SU; Yang DS; Kim AR; Lee JB; Kim YH; Kim JS; Seo JH
    Tumour Biol; 2014 Jan; 35(1):277-86. PubMed ID: 23918300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.
    Jensen BV; Johansen JS; Price PA
    Clin Cancer Res; 2003 Oct; 9(12):4423-34. PubMed ID: 14555515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor expression in anal canal carcinoma.
    Lê LH; Chetty R; Moore MJ
    Am J Clin Pathol; 2005 Jul; 124(1):20-3. PubMed ID: 15923158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
    Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40, a new prognostic biomarker in cancer patients?
    Johansen JS; Jensen BV; Roslind A; Nielsen D; Price PA
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):194-202. PubMed ID: 16492905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children.
    Santos CB; Davidson J; Covar RA; Spahn JD
    Ann Allergy Asthma Immunol; 2014 Sep; 113(3):263-6. PubMed ID: 24954373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40: a new biomarker in cardiovascular disease?
    Mathiasen AB; Henningsen KM; Harutyunyan MJ; Mygind ND; Kastrup J
    Biomark Med; 2010 Aug; 4(4):591-600. PubMed ID: 20701447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitinase-like proteins in lung injury, repair, and metastasis.
    Lee CG; Dela Cruz CS; Ma B; Ahangari F; Zhou Y; Halaban R; Sznol M; Elias JA
    Proc Am Thorac Soc; 2012 May; 9(2):57-61. PubMed ID: 22550243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast.
    Roslind A; Balslev E; Kruse H; Staergaard B; Horn T
    Ultrastruct Pathol; 2008; 32(3):101-6. PubMed ID: 18570155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
    Thöm I; Andritzky B; Schuch G; Burkholder I; Edler L; Johansen JS; Bokemeyer C; Schumacher U; Laack E
    Cancer; 2010 Sep; 116(17):4114-21. PubMed ID: 20564116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma YKL-40: a potential new cancer biomarker?
    Johansen JS; Schultz NA; Jensen BV
    Future Oncol; 2009 Sep; 5(7):1065-82. PubMed ID: 19792974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer.
    Fan JT; Si XH; Liao Y; Shen P
    Arch Gynecol Obstet; 2013 Jan; 287(1):111-5. PubMed ID: 22945838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.